Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (5401)	1/29/1998 8:30:00 AM
From: Robert K.	Respond to of 17367

Off topic-clinton.......................................................... ....The reason he got elected in the first place was that back in 92 he looked the camera straight in the lens and swore he never had sex or whatever with flowers. Now he admits he did. Now he swears straight into the lens again he never had sex or whatever with lewinsky. Well he got the benefit of the doubt from me the first time, but not any more. Too many weird occurences not to know something happened. Add that to all the other things he slid out of and he must think we a a bunch of dopes. I do agree that what he does privately is his business but lies to the court and coverups and lies to the public are not the makings of a person deserving of office. Like asia, the problem might be swept under the carpet temporarily, but this thing is gonna come back with a vengence. I would respect him some if he just said yes I did it, or Its none of your business etc...but those lies now. No more. or

To: Tharos who wrote (5401)	1/29/1998 10:49:00 AM
From: aknahow	Read Replies (2) \| Respond to of 17367

Tharos, once more I wish to remind anyone iterested in biotech stocks that articles by Jesse Eisenger at thestreet.com are esential. Read todays article on CORR. I own no CORR having had mine called away sometime ago. The importance of the article is in the insights provided into the workings of the FDA and the thoughts of institutionl investors in Biotech. I am not a shill for TSC but I do want them to be a smashing sucess so they will continue their work in an area that may be simply a diversion for Cramer that will be abandonded if it is not profitable. thestreet.com